- Patient-reported outcome measures for technology assessment:... 2026-03-23
- Deep learning radiomic analysis in the prediction of MYCN st... 2026-03-23
- Lactylation in pancreatic cancer: From molecular mechanisms ... 2026-03-23
- Endothelial metabolic reprogramming influences tumor immune ... 2026-03-23
- Evolving and novel applications of artificial intelligence i... 2026-03-23
World Journal of Clinical Oncology (WJCO, World J Clin Oncol) is a high-quality, open-access academic journal that employs a single-blind peer-review process. The journal focuses on publishing clinical, basic, and translational research achievements that are innovative, novel, and practical in the fields of oncology. The types of articles published in WJCO include Editorial, Opinion Review, Frontier, Review, Minireview, Clinical Research, Basic Study, Systematic Review, Meta-analysis, Evidence-based Medicine, Field of Vision, Clinical Guidelines, Letter to the Editor, and Case Report. All submissions must comply with academic norms and ethical requirements. WJCO is edited and published by the Baishideng Publishing Group. Submit here >>
- Hiten R H Patel, PhD, Professor, (hrhpatel@hotmail.com) Department of Urology, University Hospital North Norway, Tromso 9038, Norway
The 2025 edition of Journal Citation Reports® cites the 2024 journal impact factor (JIF) for WJCO as 3.2; JIF without journal self cites: 3.1; 5-year JIF: 3.2; JIF Rank: 129/326 in oncology; JIF Quartile: Q2; and 5-year JIF Quartile: Q2.





